Cefepime
Active substance: cefepime
INJECTION, POWDER, FOR SOLUTION · CEFEPIME HYDROCHLORIDE 500 mg/1
United StatesActive
Marketing holder: Qilu Pharmaceutical Co., Ltd.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- CEFEPIME HYDROCHLORIDE · 500 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 61 |
|
| EU 1 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2fc1-73ff-a700-d9d30e4a8fb5,01a120c3-2fef-795f-8440-2d6811a52a56,01a120c3-4f4c-76d3-969f-aeb7b5dec01c,01a120c3-715a-748f-8521-c1002e4d6d03,01a120c3-727f-7318-b213-7fe7b64c8abe;count=43 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-58e4-74dd-a8aa-d60991764263,01a1208c-5928-7058-a072-17d73241996a,01a1208c-83fc-7510-adc6-644909a67e1c,01a1208c-9e88-7dc8-b3b2-bdd4a9e7c4f7,01a1208d-6936-7f4c-82fc-6dd8a8371d25;count=27 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 67184-1002
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS
- product · openFDA NDC · 67184-1002 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 67184-1002 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 67184-1002 · Verified 2026-10-09 · open in source